Let's Talk Alzheimer's

Lewy Body, Alzheimer’s & Mixed Dementias Explained | Dr. James Galvin

Lewy body dementia is a form of dementia caused by abnormal protein deposits in the brain known as "Lewy bodies,” with symptoms that can resemble those of Parkinson's dis

Managing Agitation in Alzheimer's Dementia | Dr. Brent Forester

Agitation is one of the most common and challenging symptoms of Alzheimer’s disease, often causing distress for both individuals living with dementia and their caregivers

Stroke, Vascular Dementia, Alzheimer’s: What’s the Difference? | Dr. Jason Hinman

Vascular dementia is the second-most common form of dementia and often develops after a stroke. In this episode, Dr. Jason Hinman of UCLA explains how disrupted blood flo

The Gut-Brain Connection: How the Microbiome May Influence Alzheimer’s Risk | Dr. Beau Ances

Could the trillions of bacteria in your gut affect your brain health and risk for Alzheimer’s disease? Emerging research suggests the gut microbiome may play an important

Alzheimer’s and Gum Disease: Exploring the Role of Oral Bacteria in Brain Health | Dr. Michael Detke

Could bacteria linked to gum disease play a role in Alzheimer’s disease? Emerging science suggests that P. gingivalis, a bacterium associated with gum disease, may contri

Inside the Alzheimer’s Drug Pipeline: What New Clinical Trials Mean for the Future | Dr. Jeffrey Cummings

Exciting advances in understanding Alzheimer’s biology, genetics, and biomarkers are driving new medicines, devices, and prevention strategies. In 2025 alone, 182 clinica

Lifestyle & Brain Health: U.S. POINTER Study | Dr. Laura D. Baker

Can everyday lifestyle choices really protect your memory? Dr. Laura Baker, professor at Wake Forest University School of Medicine, shares insights from the groundbreakin

Detecting Alzheimer’s: How to Recognize Early Signs | Dr. Sharon Cohen

Detecting subtle changes in memory or thinking can be unsettling, but understanding what’s behind those changes can lead to critical early diagnosis—or even rule out Alzh

Leqembi & Kisunla: New Alzheimer's Treatments Explained | Dr. Armen J. Moughamian

Just three years ago, there were no FDA-approved treatments that targeted the underlying causes of Alzheimer’s—only medications that modified symptoms. Today, two FDA-app